MRNA - Spark Newswire

1 minute read

US Health Official Says Updated COVID-19 Boosters Should Offer Protection Amid Tracking Emerging Variants

Today, 11:07 AM

The U.S. health officials are tracking several coronavirus omicron subvariants that more easily evade immunity, rendering many treatments ineffective. But the new booster shots should provide protection, said Dr. Ashish Jha, head of the White House Covid task force.

MRNA

1 minute read

The European Commission Authorized the Conversion of the Conditional Marketing Authorization for Moderna’s Spikevax to Standard Marketing Authorization

By Charles Gross

Today, 11:07 AM

https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/covid-19-latest-updates

MRNA

2 minute read

Check Out What Whales Are Doing With MRNA

By Benzinga Insights

Today, 11:07 AM

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

MRNA

4 minute read

Google Now Shuts Down Translate App In China, Moderna-China COVID-19 Sales Talk Collapse, Disney-Dish Temporary Accord Ends Weekend Blackout: Top Stories Monday, Oct. 03

By Vandana Singh

Today, 11:07 AM

Wall Street Journal

AMZN

1 minute read

News

Moderna Refused China Request to Reveal Vaccine Technology

By Charles Gross

Today, 11:07 AM

-FT https://www.ft.com/content/a481c129-c5aa-4972-84a8-3a45bb000098

MRNA

1 minute read

News

‘Ohio reports state’s first death from monkeypox, raising U.S. death toll to 3’ -BNO Report

By Benzinga Newsdesk

Today, 11:07 AM

https://twitter.com/BNOFeed/status/1575847127166713860

AEMD

1 minute read

Europe’s Health Agency Accepts Moderna’s Filing For Its Updated Omicron-Targeted COVID-19 Vaccine

By Vandana Singh

Today, 11:07 AM

The European Medicines Agency (EMA) has accepted a variation for evaluating Moderna Inc’s (NASDAQ:MRNA) 50 µg booster dose of the Omicron-containing…

MRNA

1 minute read

As Moderna Grapples With Supply Shortage, FDA Gives Nod To Additional Lots of COVID-19 Booster

By Vandana Singh

Today, 11:07 AM

The FDA authorized an additional five batches of Moderna Inc’s (NASDAQ:MRNA) updated Covid booster shots made at Catalent Inc‘s (NYSE:CTLT) Indiana facility after…

BNTX

2 minute read

Moderna Seeks FDA Approval For Updated COVID-19 Shot For Kids, But Scrambles Supply Challenges

By Vandana Singh

Today, 11:07 AM

Last week, Moderna Inc (NASDAQ: MRNA) said it asked the FDA to authorize the use of its updated booster shot in children ages 6 to 17. The company expects to complete a request for the use of the booster in children six months through 5 years later this year.

BNTX

1 minute read

Cramer On COVID-19 Vaccine Stock: ‘I Know It Can Go Lower, But I Think It’s A Really Well-Run Company’

By Lisa Levin

Today, 11:07 AM

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he wants to buy Moderna, Inc. (NASDAQ: MRNA). "I know it can go lower, but I think it’s a really well-run company," he added.

CCI

Feed Symbols: MRNA